VALUE: analysis of results

This publication has 5 references indexed in Scilit:

• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
  The Lancet, 2004
• Antihypertensive Therapy and Incidence of Type 2 Diabetes
  Diabetes Care, 2004
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
  Drugs, 2004
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
  The Lancet, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002